BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Early pregnancy factor
,
Doxycycline
,
rs3825942
,
LEP
,
nitric oxide metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MHC class II protein
Summary
General Info
Curated Studies
Most Correlated Studies
T cells adoptively transferred sorted from lymph nodes after moth cytochrome c protein treatment
Peripheral blood monocytes response to soluble MHC Class II
CD4+ and CD8+ T cells from TCR transgenic mice stimulated in vitro and in vivo
Skin-derived precursor cells treated with a cocktail of inflammatory cytokines
CD8+ T cells resistant or sensitive to cyclosporine
Explore Curated Studies Results
Literature
Most Relevant Literature
Next-generation sequencing identifies two novel HLA-DRB1 alleles, HLA-DRB1*04:362 and HLA-DRB1*07:14…
Description of two new HLA alleles: HLA-DRB1*11:262 and HLA-DRB1*11:268.
Identification of a new HLA-DRB1 allele, HLA-DRB1*04:361.
Extended genomic sequence of the HLA-DRB1*13:129 allele identified in a donor from the Gujarati popu…
Characterization of the novel HLA-DRB1 allele, HLA-DRB1*04:328 in a Chinese individual.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 Diabetes
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage …
CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-deri…
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ